Chemical biology of tetracycline antibiotics

Biochemistry and Cell Biology

Volumn 86, Issue 2, 2008, Pages 124-136

  Zakeri, Bijan ^a   Wright, Gerard D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Antibiotic; Biosynthesis; Resistance; Tetracycline

Indexed keywords

BACTERIAL RESISTANCE; CHEMICAL BIOLOGY; DRUG DESIGN;

BACTERIA; BIOSYNTHESIS; DISEASES; DRUG DELIVERY;

ANTIBIOTICS;

6 THIATETRACYCLINE; AMINOGLYCOSIDE DERIVATIVE; BETA LACTAM DERIVATIVE; CHELOCARDIN; CHLORTETRACYCLINE; DOXYCYCLINE; MINOCYCLINE; OXYTETRACYCLINE; QUINOLONE DERIVATIVE; TETRACYCLINE DERIVATIVE; TIGECYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CHEMICAL REACTION; CONFERENCE PAPER; DRUG ACTIVITY; DRUG BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; ENZYME INACTIVATION; GENE EXPRESSION; GENE MUTATION;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PROTEINS; DRUG DESIGN; DRUG RESISTANCE, BACTERIAL; ENZYME INHIBITORS; HUMANS; MOLECULAR STRUCTURE; RNA, RIBOSOMAL; TETRACYCLINES;

BACTERIA (MICROORGANISMS);

EID: 42149157706     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/O08-002     Document Type: Conference Paper

References (87)

1. Acharya, M.R., Venitz, J., Figg, W.D., and Sparreboom, A. 2004. Chemically modified tetracyclines as inhibitors of matrix metalloproteinases. Drug Resist. Updat. 7: 195-208. doi:10.1016/j.drup.2004.04.002. PMID:15296861.
2. Agwuh, K.N., and MacGowan, A. 2006. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J. Antimicrob. Chemother. 58: 256-265. doi:10.1093/jac/dkl224. PMID:16816396.
3. Auerbach, T., Bashan, A., Harms, J., Schluenzen, F., Zarivach, R., Bartels, H., et al. 2002. Antibiotics targeting ribosomes: crystallographic studies. Curr. Drug Targets Infect. Disord. 2: 169-186. doi:10.2174/1568005023342506. PMID:12462147.
4. Ball, P.R., Shales, S.W., and Chopra, I. 1980. Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic. Biochem. Biophys. Res. Commun. 93: 74-81. doi:10.1016/S0006-291X(80)80247-6. PMID:6990931.
5. Baltz, R.H. 2005. Antibiotic discovery from actinomycetes: Will a renaissance follow the decline and fall? SIM News, 55: 186-196.
6. Barbatschi, F., Dann, M., Martin, J.H., Miller, P., Mitscher, L.A., and Bohonos, N. 1965. 4-Dedimethylamino-4-epiamino-5a,6-anhydrotetracycline. Experientia, 21: 162-163. doi:10.1007/BF02141995. PMID:5830054.
7. Brodersen, D.E., Clemons, W.M., Jr., Carter, A.P., Morgan-Warren, R.J., Wimberly, B.T., and Ramakrishnan, V. 2000. The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell, 103: 1143-1154. doi:10.1016/S0092-8674(00)00216- 6. PMID: 11163189.
8. Burdett, V. 1991. Purification and characterization of Tet(M), a protein that renders ribosomes resistant to tetracycline. J. Biol. Chem. 266: 2872-2877. PMID:1993661.
9. Burdett, V. 1996. Tet(M)-promoted release of tetracycline from ribosomes is GTP dependent. J. Bacteriol. 178: 3246-3251. PMID:8655505.
10. Challis, G.L., and Hopwood, D.A. 2003. Synergy and contingency as driving forces for the evolution of multiple secondary metabolite production by Streptomyces species. Proc. Natl. Acad. Sci. U.S.A. 100(Suppl 2): 14555-14561. doi:10.1073/pnas.1934677100. PMID:12970466.
11. Charest, M.G., Siegel, D.R., and Myers, A.G. 2005a. Synthesis of (-)-tetracycline. J. Am. Chem. Soc. 127: 8292-8293. doi:10.1021/ ja052151d. PMID:15941256.
12. Charest, M.G., Lerner, C.D., Brubaker, J.D., Siegel, D.R., and Myers, A.G. 2005b. A Convergent enantioselective route to structurally diverse 6-deoxytetracycline antibiotics. Science, 308: 395-398. doi:10.1126/science.1109755. PMID:15831754.
13. Chopra, I. 1994. Tetracycline analogs whose primary target is not the bacterial ribosome. Antimicrob. Agents Chemother. 38: 637-640. PMID:8031024.
14. Chopra, I., and Roberts, M. 2001. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65: 232-260. doi:10.1128/MMBR.65. 2.232-260.2001. PMID:11381101.
15. Chopra, I., Hawkey, P.M., and Hinton, M. 1992. Tetracyclines, molecular and clinical aspects. J. Antimicrob. Chemother. 29: 245-277. doi:10.1093/jac/29.3.245. PMID:1592696.
16. Christoffersen, R.E. 2006. Antibiotics - an investment worth making? Nat. Biotechnol. 24: 1512-1514. doi:10.1038/nbt1206-1512. PMID:17160052.
17. Connell, S.R., Tracz, D.M., Nierhaus, K.H., and Taylor, D.E. 2003. Ribosomal protection proteins and their mechanism of tetracycline resistance. Antimicrob. Agents Chemother. 47: 3675-3681. doi:10.1128/AAC.47.12.3675- 3681.2003. PMID:14638464.
18. Cundliffe, E. 1989. How antibiotic-producing organisms avoid suicide. Annu. Rev. Microbiol. 43: 207-233. doi:10.1146/annurev.mi.43.100189. 001231. PMID:2679354.
19. D'Costa, V.M., McGrann, K.M., Hughes, D.W., and Wright, G.D. 2006. Sampling the antibiotic resistome. Science, 311: 374-377. doi:10.1126/science.1120800. PMID:16424339.
20. Davies, J. 1994. Inactivation of antibiotics and the dissemination of resistance genes. Science, 264: 375-382. doi:10.1126/science.8153624. PMID:8153624.
21. Degenkolb, J., Takahashi, M., Ellestad, G.A., and Hillen, W. 1991. Structural requirements of tetracycline-Tet repressor interaction: determination of equilibrium binding constants for tetracycline analogs with the Tet repressor. Antimicrob. Agents Chemother. 35: 1591-1595. PMID:1929330.
22. Duggar, B.M. 1948. Aureomycin: a product of the continuing search for new antibiotics. Ann. N. Y. Acad. Sci. 51: 177-181. doi:10.1111/j.1749-6632. 1948.tb27262.x. PMID:18112227.
23. Eckert, B., and Beck, C.F. 1989. Overproduction of transposon Tn10-encoded tetracycline resistance protein results in cell death and loss of membrane potential. J. Bacteriol. 171: 3557-3559. PMID:2542231.
24. Epe, B., and Woolley, P. 1984. The binding of 6-demethylchlortetracycline to 70S, 50S and 30S ribosomal particles: a quantitative study by fluorescence anisotropy. EMBO J. 3: 121-126. PMID:6423382.
25. Fernandes, P. 2006. Antibacterial discovery and development - the failure of success? Nat. Biotechnol. 24: 1497-1503. doi:10.1038/nbt1206-1497. PMID:17160049.
26. Guiney, D.G., Jr., Hasegawa, P., and Davis, C.E. 1984. Expression in Escherichia coli of cryptic tetracycline resistance genes from Bacteroides R plasmids. Plasmid, 11: 248-252. doi:10.1016/0147- 619X(84)90031-3. PMID:6379711.
27. Hertweck, C., Luzhetskyy, A., Rebets, Y., and Bechthold, A. 2007. Type II polyketide synthases: gaining a deeper insight into enzymatic teamwork. Nat. Prod. Rep. 24: 162-190. doi:10.1039/b507395m. PMID:17268612.
28. Hidalgo, M., and Eckhardt, S.G. 2001. Development of matrix metalloproteinase inhibitors in cancer therapy. J. Natl. Cancer Inst. 93: 178-193. doi:10.1093/jnci/93.3.178. PMID:11158186.
29. Hillen, W., and Berens, C. 1994. Mechanisms underlying expression of Tn10 encoded tetracycline resistance. Annu. Rev. Microbiol. 48: 345-369. doi:10.1146/annurev.mi.48.100194.002021. PMID:7826010.
30. Hinrichs, W., Kisker, C., Duvel, M., Muller, A., Tovar, K., Hillen, W., and Saenger, W. 1994. Structure of the Tet repressor-tetracycline complex and regulation of antibiotic resistance. Science, 264: 418-420. doi:10.1126/science.8153629. PMID:8153629.
31. Hubbard, B.K., and Walsh, C.T. 2003. Vancomycin assembly: nature's way. Angew. Chem. Int. Ed. Engl. 42: 730-765. doi:10.1002/anie.200390202. PMID:12596194.
32. Hughes, L.J., Stezowski, J.J., and Hughes, R.E. 1979. Chemical-structural properties of tetracycline derivatives. 7. Evidence for the coexistence of the zwitterionic and nonionized forms of the free base in solution. J. Am. Chem. Soc. 101: 7655-7657. doi:10.1021/ja00520a003.
33. Kohanski, M.A., Dwyer, D.J., Hayete, B., Lawrence, C.A., and Collins, J.J. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell, 130: 797-810. doi:10.1016/j.cell.2007.06.049. PMID:17803904.
34. Lai, J.R., Koglin, A., and Walsh, C.T. 2006. Carrier protein structure and recognition in polyketide and nonribosomal peptide biosynthesis. Biochemistry, 45: 14869-14879. doi:10.1021/bi061979p. PMID:17154525.
35. Linares, J.F., Gustafsson, I., Baquero, F., and Martinez, J.L. 2006. Antibiotics as intermicrobial signalling agents instead of weapons. Proc. Natl. Acad. Sci. U.S.A. 103: 19484-19489. doi:10.1073/pnas.0608949103. PMID:17148599.
36. Liou, G.F., and Khosla, C. 2003. Building-block selectivity of polyketide synthases. Curr. Opin. Chem. Biol. 7: 279-284. doi:10.1016/S1367- 5931(03)00016-4. PMID:12714062.
37. Lomovskaya, O., and Watkins, W.J. 2001. Efflux pumps: their role in antibacterial drug discovery. Curr. Med. Chem. 8: 1699-1711. PMID:11562289.
38. Maxwell, I.H. 1967. Partial removal of bound transfer RNA from polysomes engaged in protein synthesis in vitro after addition of tetracycline. Biochim. Biophys. Acta, 138: 337-346. PMID:4963397.
39. McCormick, J.R., and Jensen, E.R. 1965. Biosynthesis of The Tetracyclines. VIII. Characterization of 4-hydroxy-6-methylpretetramid. J. Am. Chem. Soc. 87: 1794-1795. doi:10.1021/ja01086a034. PMID:14289339.
40. McCormick, J.R., and Jensen, E.R. 1969. Biosynthesis of the tetracyclines. XII. Anhydrodemethylchlortetracycline from a mutant of Streptomyces aureofaciens. J. Am. Chem. Soc. 91: 206. doi:10.1021/ja01029a046. PMID:5782458.
41. McCormick, J.R., Joachim, U.H., Jensen, E.R., Johnson, S., and Sjolander, N.O. 1965. Biosynthesis of the tetracyclines. VII. 4-Hydroxy-6- methylpretetramid, an intermediate accumulated by a blocked mutant of Streptomyces aureofaciens. J. Am. Chem. Soc. 87: 1793-1794. doi:10.1021/ja01086a033. PMID:14289338.
42. McCormick, J.R., Jensen, E.R., Johnson, S., and Sjolander, N.O. 1968. Biosynthesis of the tetracyclines. IX. 4- Aminodedimethylaminoanhydrodemethylchlortetracycline from a mutant of Streptomyces aureofaciens. J. Am. Chem. Soc. 90: 2201-2202. doi:10.1021/ja01010a063. PMID:5641578.
43. McMurry, L., Petrucci, R.E., and Levy, S.B. 1980. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 77: 3974-3977. doi:10.1073/pnas.77.7.3974. PMID:7001450.
44. Miller, P.A., Saturnelli, A., Martin, J.H., Itscher, L.A., and Bohonos, N. 1964. A new family of tetracycline precursors. N-Demethylanhydrotetracyclines. Biochem. Biophys. Res. Commun. 16: 285-291. doi:10.1016/0006-291X(64)90341-9. PMID:4959040.
45. Moore, B.S., and Hertweck, C. 2002. Biosynthesis and attachment of novel bacterial polyketide synthase starter units. Nat. Prod. Rep. 19: 70-99. doi:10.1039/b003939j. PMID:11902441.
46. Moore, I.F., Hughes, D.W., and Wright, G.D. 2005. Tigecycline is modified by the flavin-dependent monooxygenase TetX. Biochemistry, 44: 11829-11835. doi:10.1021/bi0506066. PMID:16128584.
47. Mueller, F., and Brimacombe, R. 1997. A new model for the three-dimensional folding of Escherichia coli 16 S ribosomal RNA. I. Fitting the RNA to a 3D electron microscopic map at 20A. J. Mol. Biol. 271: 524-544. doi:10.1006/jmbi.1997.1210. PMID:9281424.
48. Muxfeldt, H., Haas, G., Hardtmann, G., Kathawala, F., Mooberry, J.B., and Vedejs, E. 1979. Tetracyclines. 9. Total synthesis of DL-terramycin. J. Am. Chem. Soc. 101: 689-701. doi:10.1021/ja00497a035.
49. Nakano, T., Miyake, K., Endo, H., Dairi, T., Mizukami, T., and Katsumata, R. 2004. Identification and cloning of the gene involved in the final step of chlortetracycline biosynthesis in Streptomyces aureofaciens. Biosci. Biotechnol. Biochem. 68: 1345-1352. doi:10.1271/bbb.68.1345. PMID:15215601.
50. Nelson, M.L. 2002. The chemistry and biology of the tetracyclines. In Annual reports in medicinal chemistry. Vol. 37. Academic Press, Chap 11. pp. 105-114.
51. Nelson, M.L., Park, B.H., and Levy, S.B. 1994. Molecular requirements for the inhibition of the tetracycline antiport protein and the effect of potent inhibitors on the growth of tetracycline-resistant bacteria. J. Med. Chem. 37: 1355-1361. doi:10.1021/jm00035a016. PMID:8176712.
52. Nikaido, H., and Thanassi, D.G. 1993. Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples. Antimicrob. Agents Chemother. 37: 1393-1399. PMID:8363364.
53. Oliva, B., and Chopra, I. 1992. Tet determinants provide poor protection against some tetracyclines: further evidence for division of tetracyclines into two classes. Antimicrob. Agents Chemother. 36: 876-878. PMID:1503452.
54. Oliva, B., Gordon, G., McNicholas, P., Ellestad, G., and Chopra, I. 1992. Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli. Antimicrob. Agents Chemother. 36: 913-919. PMID:1510413.
55. Pandza, K., Pfalzer, G., Cullum, J., and Hranueli, D. 1997. Physical mapping shows that the unstable oxytetracycline gene cluster of Streptomyces rimosus lies close to one end of the linear chromosome. Microbiology, 143: 1493-1501. PMID:9168599.
56. Park, B.H., and Levy, S.B. 1988. The cryptic tetracycline resistance determinant on Tn4400 mediates tetracycline degradation as well as tetracycline efflux. Antimicrob. Agents Chemother. 32: 1797-1800. PMID:3072922.
57. Paulsen, I.T., Brown, M.H., and Skurray, R.A. 1996. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60: 575-608. PMID:8987357.
58. Peric-Concha, N., Borovicka, B., Long, P.F., Hranueli, D., Waterman, P.G., and Hunter, I.S. 2005. Ablation of the otcC gene encoding a post-polyketide hydroxylase from the oxytetracyline biosynthetic pathway in Streptomyces rimosus results in novel polyketides with altered chain length. J. Biol. Chem. 280: 37455-37460. doi:10.1074/jbc.M503191200. PMID:16148009.
59. Petkovic, H., Thamchaipenet, A., Zhou, L.H., Hranueli, D., Raspor, P., Waterman, P.G., and Hunter, I.S. 1999. Disruption of an aromatase/cyclase from the oxytetracycline gene cluster of Streptomyces rimosus results in production of novel polyketides with shorter chain lengths. J. Biol. Chem. 274: 32829-32834. PMID:10551844.
60. Pioletti, M., Schlunzen, F., Harms, J., Zarivach, R., Gluhmann, M., Avila, H., et al. 2001. Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3. EMBO J. 20: 1829-1839. doi:10.1093/emboj/20.8.1829. PMID:11296217.
61. Poole, K. 2005. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56: 20-51. doi:10.1093/jac/dki171. PMID:15914491.
62. Poole, K. 2007. Efflux pumps as antimicrobial resistance mechanisms. Ann. Med. 39: 162-176. doi:10.1080/07853890701195262. PMID:17457715.
63. Ramos, J.L., Martinez-Bueno, M., Molina-Henares, A.J., Teran, W., Watanabe, K., Zhang, X., et al. 2005. The TetR family of transcriptional repressors. Microbiol. Mol. Biol. Rev. 69: 326-356. doi:10.1128/MMBR.69. 2.326-356.2005. PMID:15944459.
64. Rasmussen, B., Noller, H.F., Daubresse, G., Oliva, B., Misulovin, Z., Rothstein, D.M., et al. 1991. Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrob. Agents Chemother. 35: 2306-2311. PMID:1725100.
65. Roberts, M.C. 1996. Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiol. Rev. 19: 1-24. doi:10.1111/j.1574-6976.1996.tb00251.x. PMID:8916553.
66. Roberts, M.C. 2003. Tetracycline therapy: update. Clin. Infect. Dis. 36: 462-467. doi:10.1086/367622. PMID:12567304.
67. Roberts, M.C. 2005. Update on acquired tetracycline resistance genes. FEMS Microbiol. Lett. 245: 195-203. doi:10.1016/j.femsle.2005.02.034. PMID:15837373.
68. Roberts, M.C. 2007. Mechanism of resistance for characterized tet and otr genes [online]. Available from http://faculty.washington.edu/ marilynr/tetweb1.pdf [cited August 2007].
69. Ross, J.I., Eady, E.A., Cove, J.H., and Cunliffe, W.J. 1998. 16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrob. Agents Chemother. 42: 1702-1705. PMID:9661007.
70. Ryan, M.J. 1999. Strain for the production of 6-dimethyltetracycline, method for producing the strain and vector for use in the method. US Patent 5989903.
71. Sapadin, A.N., and Fleischmajer, R. 2006. Tetracyclines: nonantibiotic properties and their clinical implications. J. Am. Acad. Dermatol. 54: 258-265. doi:10.1016/j.jaad.2005.10.004. PMID:16443056.
72. Schnappinger, D., and Hillen, W. 1996. Tetracyclines: antibiotic action, uptake, and resistance mechanisms. Arch. Microbiol. 165: 359-369. doi:10.1007/s002030050339. PMID:8661929.
73. Slover, C.M., Rodvold, K.A., and Danziger, L.H. 2007. Tigecycline: a novel broad-spectrum antimicrobial. Ann. Pharmacother. 41: 965-972. doi:10.1345/aph.1H543. PMID:17519296.
74. Spahn, C.M., Blaha, G., Agrawal, R.K., Penczek, P., Grassucci, R.A., Trieber, C.A., et al. 2001. Localization of the ribosomal protection protein Tet(O) on the ribosome and the mechanism of tetracycline resistance. Mol. Cell, 7: 1037-1045. doi:10.1016/S1097-2765(01)00238-6. PMID:11389850.
75. Speer, B.S., and Salyers, A.A. 1988. Characterization of a novel tetracycline resistance that functions only in aerobically grown Escherichia coli. J. Bacteriol. 170: 1423-1429. PMID:2832361.
76. Speer, B.S., Shoemaker, N.B., and Salyers, A.A. 1992. Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance. Clin. Microbiol. Rev. 5: 387-399. PMID:1423217.
77. Stokstad, E.L.R., Jukes, T.H., Pierce, J., Page, A.C., Jr., and Franklin, A.L. 1949. The multiple nature of the animal protein factor. J. Biol. Chem. 180: 647-654. PMID:18135798.
78. Sum, P.E., and Petersen, P. 1999. Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of Gar-936. Bioorg. Med. Chem. Lett. 9: 1459-1462. doi:10.1016/S0960- 894X(99)00216-4. PMID:10360756.
79. 2+ concentrations: a generally applicable method for effector-dependent high-affinity complexes. Anal. Biochem. 199: 197-202. doi:10.1016/0003-2697(91)90089-C. PMID:1812784.
80. Tritton, T.R. 1977. Ribosome-tetracycline interactions. Biochemistry, 16: 4133-4138. doi:10.1021/bi00637a029. PMID:334241.
81. Watanabe, T. 1963. Infective heredity of multiple drug resistance in bacteria. Bacteriol. Rev. 27: 87-115. PMID:13999115.
82. White, J.P., and Cantor, C.R. 1971. Role of magnesium in the binding of tetracycline to Escherichia coli ribosomes. J. Mol. Biol. 58: 397-400. doi:10.1016/0022-2836(71)90255-5. PMID:4932658.
83. Wright, G.D. 2007. The antibiotic resistome: the nexus of chemical and genetic diversity. Nat. Rev. Microbiol. 5: 175-186. doi:10.1038/ nrmicro1614. PMID:17277795.
84. Yang, W., Moore, I.F., Koteva, K.P., Bareich, D.C., Hughes, D.W., and Wright, G.D. 2004. TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics. J. Biol. Chem. 279: 52346-52352. doi:10.1074/jbc.M409573200. PMID:15452119.
85. Zarivach, R., Bashan, A., Schluenzen, F., Harms, J., Pioletti, M., Franceschi, F., and Yonath, A. 2002. Initiation and inhibition of protein biosynthesis studies at high resolution. Curr. Protein Pept. Sci. 3: 55-65. doi:10.2174/1389203023380800. PMID:12370011.
86. Zhang, W., Ames, B.D., Tsai, S.C., and Tang, Y. 2006. Engineered biosynthesis of a novel amidated polyketide, using the malonamyl-specific initiation module from the oxytetracycline polyketide synthase. Appl. Environ. Microbiol. 72: 2573-2580. doi:10.1128/AEM.72.4.2573-2580.2006. PMID:16597959.
87. Zhang, W., Watanabe, K., Wang, C.C., and Tang, Y. 2007. Investigation of early tailoring reactions in the oxytetracycline biosynthetic pathway. J. Biol. Chem. 282: 25717-25725. doi:10.1074/jbc.M703437200. PMID:17631493.